ETF Managers Group’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,358	Closed	-$19K	–	807
2022 Q2	$19K	Buy	1,358 +39	+3%	+$546	﹤0.01%	737
2022 Q1	$34K	Sell	1,319 -1	-0.1%	-$26	﹤0.01%	670
2021 Q4	$105K	Buy	+1,320	New	+$105K	﹤0.01%	637